This study described 25 incident cases of psoriasis, and an increased incidence of psoriasiform reactions was observed among the patients treated with TNF-α inhibitors (1.04 per 1000 person years) compared with that seen in the patients treated with traditional disease-modifying antirheumatic drugs (0 per person per year) [48]. The gene discussed is TNF; the disease is psoriasis.